{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T03:35:49Z","timestamp":1772595349291,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.rmed.2022.106986","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T06:52:18Z","timestamp":1663311138000},"page":"106986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Does baricitinib reduce mortality and disease progression in SARS-CoV-2 virus infected patients? A systematic review and meta analysis"],"prefix":"10.1016","volume":"202","author":[{"given":"Sivananthan","family":"Manoharan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee Ying","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2022.106986_bib1","series-title":"Covid-19 Coronavirus Pandemic","year":"2021"},{"key":"10.1016\/j.rmed.2022.106986_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243705","article-title":"Efficacy and harms of remdesivir for the treatment of COVID-19: a systematic review and meta-analysis","volume":"15","author":"Piscoya","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2022.106986_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243042","article-title":"Continued proportional age shift of confirmed positive COVID-19 incidence over time to children and young adults: Washington State March-August 2020","volume":"16","author":"Malmgren","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2022.106986_bib4","article-title":"Stay home so this can be over: a national study of youth perspectives on social distancing during the COVID-19 pandemic","volume":"22","author":"Dunn","year":"2021","journal-title":"Prevent Med Reports"},{"key":"10.1016\/j.rmed.2022.106986_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.rmed.2022.106986_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of covid-19 vaccines against the B.1.617.2 (Delta) variant","volume":"385","author":"Bernal","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2022.106986_bib7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.rmed.2022.106986_bib8","series-title":"Therapeutics and COVID-19: Living Guideline","year":"2021"},{"key":"10.1016\/j.rmed.2022.106986_bib9","series-title":"Know Your Treatment Options for COVID-19","year":"2021"},{"key":"10.1016\/j.rmed.2022.106986_bib10","article-title":"JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality","volume":"7","author":"Stebbing","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.rmed.2022.106986_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jinf.2020.04.017","article-title":"Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact","volume":"81","author":"Cantini","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.rmed.2022.106986_bib12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jinf.2020.06.052","article-title":"Beneficial impact of baricitinib in COVID-19 moderate pneumonia; multicentre study","volume":"81","author":"Cantini","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.rmed.2022.106986_bib13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJMe2034982","article-title":"Baricitinib therapy in covid-19 pneumonia - an unmet need fulfilled","volume":"384","author":"Goletti","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2022.106986_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106749","article-title":"Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19","volume":"86","author":"Zhang","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.rmed.2022.106986_bib15","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1172\/JCI141772","article-title":"Baricitinib restrains the immune dysregulation in patients with severe COVID-19","volume":"130","author":"Bronte","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.rmed.2022.106986_bib16","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.rmed.2022.106986_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12879-021-06119-2","article-title":"Impact of high dose of baricitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangladesh","volume":"21","author":"Hasan","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.rmed.2022.106986_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1515\/med-2021-0010","article-title":"Additional baricitinib loading dose improves clinical outcome in COVID-19","volume":"16","author":"Hasan","year":"2020","journal-title":"Open Med."},{"key":"10.1016\/j.rmed.2022.106986_bib19","first-page":"399","article-title":"Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study","volume":"60","author":"Rodriguez-Garcia","year":"2021","journal-title":"Rheumatism"},{"issue":"21","key":"10.1016\/j.rmed.2022.106986_bib20","article-title":"Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: a retrospective analysis","author":"Perez-Alba","year":"2021","journal-title":"J Microbiol Immunol Infect = Wei mian yu gan ran za zhi."},{"key":"10.1016\/j.rmed.2022.106986_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00260-2020","article-title":"D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review","volume":"6","author":"Vidali","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmed.2022.106986_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2022.106986_bib23","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.3390\/jcm10174019","article-title":"Anakinra versus baricitinib: different strategies for patients hospitalized with COVID-19","volume":"10","author":"Garc\u00eda-Garc\u00eda","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.rmed.2022.106986_bib24","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2022.106986_bib25","series-title":"Baricitinib Letter of Authorization Revised July 28 2021","year":"2021"},{"key":"10.1016\/j.rmed.2022.106986_bib26","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1111\/jgs.17357","article-title":"Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia","volume":"69","author":"Abizanda","year":"2021","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.rmed.2022.106986_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.reuma.2020.10.009","article-title":"Experience with the use of baricitinib and tocilizumab monotherapy or combined, in patients with interstitial pneumonia secondary to coronavirus covid-19: a real-world study","volume":"18","author":"Rosas","year":"2020","journal-title":"Reumatol. Cl\u00ednica"},{"key":"10.1016\/j.rmed.2022.106986_bib28","series-title":"[Computer Program]. Version 5.4","year":"2020"},{"key":"10.1016\/j.rmed.2022.106986_bib29","series-title":"GRADEpro Guideline Development Tool [Software]","year":"2020"},{"key":"10.1016\/j.rmed.2022.106986_bib30","article-title":"Baricitinib plus standard of care for hospitalised adults with covid-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: results of a randomised, placebo-controlled trial","author":"Wesley Ely","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.rmed.2022.106986_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa563","article-title":"Role of low-molecular-weight heparin in hospitalized patients with severe acute respiratory syndrome coronavirus 2 pneumonia: a prospective observational study","volume":"7","author":"Falcone","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.rmed.2022.106986_bib32","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1038\/s41375-021-01266-6","article-title":"JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis","volume":"35","author":"Chen","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.rmed.2022.106986_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108027","article-title":"Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: a systematic review and meta-analysis of randomized controlled trials","volume":"99","author":"Chen","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.rmed.2022.106986_bib34","doi-asserted-by":"crossref","first-page":"c173","DOI":"10.1159\/000262299","article-title":"Observational studies are complementary to randomized controlled trials","volume":"114","author":"Grootendorst","year":"2010","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.rmed.2022.106986_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/14787210.2021.1982695","article-title":"Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis","volume":"20","author":"Limen","year":"2021","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.rmed.2022.106986_bib36","article-title":"The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: systematic review and meta-analysis","volume":"11","author":"Wijaya","year":"2021","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.1016\/j.rmed.2022.106986_bib37","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/jmv.27482","article-title":"Clinical efficacy and adverse events of baricitinib treatment for coronavirus disease-2019 (COVID-19): a systematic review and meta-analysis","volume":"94","author":"Lin","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.rmed.2022.106986_bib38","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","first-page":"241","article-title":"Analysing data and undertaking meta-analyses","author":"Deeks","year":"2019"},{"key":"10.1016\/j.rmed.2022.106986_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8332819","article-title":"Baricitinib for the Management of SARS-CoV-2-Infected Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials","volume":"2022","author":"Manoharan","year":"2022","journal-title":"Canadian. J. Infect. Dis. Med. Microb."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611122002517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611122002517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T05:42:04Z","timestamp":1727761324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611122002517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":39,"alternative-id":["S0954611122002517"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2022.106986","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does baricitinib reduce mortality and disease progression in SARS-CoV-2 virus infected patients? A systematic review and meta analysis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2022.106986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106986"}}